Hvivo
Hvivo, a leading clinical research organisation headquartered in Great Britain, specialises in the development and testing of innovative therapies and vaccines. Founded in 2006, the company has established itself as a pioneer in the field of human challenge studies, providing unique insights into infectious diseases. With operational hubs across Europe and North America, Hvivo offers a range of services, including clinical trial management and laboratory services, that are tailored to meet the needs of biopharmaceutical clients. Notable for its state-of-the-art facilities and expertise in respiratory and viral infections, Hvivo has achieved significant milestones, including partnerships with major pharmaceutical companies. Its commitment to advancing medical research positions Hvivo as a trusted partner in the industry, driving forward the development of life-saving treatments and vaccines.
DitchCarbon Score
How does Hvivo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hvivo's score of 15 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hvivo's reported carbon emissions
In 2023, Hvivo reported total carbon emissions of approximately 148,100 kg CO2e. This figure includes 12,600 kg CO2e from Scope 1 emissions, primarily from direct fuel combustion, and a significant 78,200 kg CO2e from Scope 2 emissions, which are associated with purchased electricity. Additionally, Scope 3 emissions, which encompass indirect emissions such as business travel, accounted for about 57,300 kg CO2e. Comparatively, in 2022, Hvivo's total emissions were about 104,300 kg CO2e, with Scope 1 emissions at 63,800 kg CO2e, Scope 2 at 12,900 kg CO2e, and Scope 3 at 27,600 kg CO2e. This indicates a rise in total emissions from 2022 to 2023, reflecting an increase in operational activities or energy consumption. Despite the increase in emissions, there are currently no publicly disclosed reduction targets or climate pledges from Hvivo. The company has not set specific science-based targets for emissions reduction, which is a common practice in the industry to align with global climate goals. As such, Hvivo's commitment to addressing climate change remains unclear, and further transparency regarding their future initiatives would be beneficial for stakeholders.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 63,800 | 00,000 |
| Scope 2 | 12,900 | 00,000 |
| Scope 3 | 27,600 | 00,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hvivo is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
